儿科患者的紧急医疗服务获得的外周静脉接入率:一项回顾性研究
Paweł Samocki1,2, Robert Gałązkowski3, Patryk Rzońca4
1Department of Descriptive and Clinical Anatomy, Medical University of Warsaw, Warsaw, Poland.
概括
紧急医疗服务 (EMS) 的儿科外周静脉 (IV) 接入能力较低,特别是在婴儿中. 随着年龄,创伤,中毒和直升机紧急医疗服务 (HEMS) 转移,静脉注射管的可能性会增加.
科学领域:
- 紧急医疗 紧急医疗
- 儿科护理 儿科护理
- 医院前护理 医院前护理
背景情况:
- 周围静脉 (IV) 接入对于在医院前的药物管理至关重要.
- 儿科输液管道对医疗急救服务 (EMS) 人员在医院以外的环境中提出了重大挑战.
研究的目的:
- 评估儿科患者中EMS对外围IV接入机构的频率.
- 确定影响儿科医院前护理内静脉注射率的因素.
主要方法:
- 对6331个儿科EMS发送 (2020-2022) 的回顾性分析.
- 根据患者年龄,病例特征,ICD-10诊断和运输要求,评估管率.
- 后勤回归分析以确定IV管道的预测因素.
主要成果:
- 在16.94%的儿科患者中,获得了外围IV接入.
- 随着年龄的增长,射率显著增加 (1.03%的婴儿到75.12%的青少年).
- 年龄,创伤,中毒和直升机紧急医疗服务 (HEMS) 转移是输液管道的重要预测因素.
结论:
- 在医院前的环境中,儿科外围IV接入的总体率很低,特别是在婴儿中.
- 需要基于证据的算法和有针对性的培训,以改善EMS对重症儿童的血管接入管理.
相关概念视频
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
676
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
676
Pharmacokinetics in Pediatric Patients: Drug Distribution
231
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Pharmacokinetics in Pediatric Patients: Drug Excretion
188
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
219
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
219
Drug Dosing: Infants and Children
226
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
226
Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165


